Furthermore, inhibition of TH2 responses by anti-IL-4 antibody treatment reduced fibrosis on lymphedema and also blockade TH2 responses improved lymphatic function, without alteration expression of vascular growth factors10, 60. Here, IL4 is linked to lymphedema.